Live feed17:59:48·671dINSIDERFilingvia QuantisnowChief Financial Officer Ogden Christopher sold $2,439 worth of shares (1,984 units at $1.23) and converted options into 6,875 shares, increasing direct ownership by 5% to 108,077 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CTMX· CytomX Therapeutics Inc.Health CareOriginal source